By: Jeff Cohen
The latest healthcare marketing prosecution in the Florida laboratory space came when criminal charges were filed against Mr. John Skeffington on December 6th. The case is unique because it involves (a) purely commercially insureds (no governmental patients), (b) it is aimed entirely at marketing practices, and (c) is seems to target (the allegedly illegal contract was not attached) pure incentive compensation (percentage based in this case). The case will certainly get a lot of attention, since it may be signaling enhanced federal enforcement of purely commercial payer arrangements sources, marketing activities, lab marketing relationships and percentage based compensation arrangements.Continue reading
